OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rapalogs and mTOR inhibitors as anti-aging therapeutics
Dudley W. Lamming, Lan Ye, David M. Sabatini, et al.
Journal of Clinical Investigation (2013) Vol. 123, Iss. 3, pp. 980-989
Open Access | Times Cited: 487

Showing 26-50 of 487 citing articles:

Current treatment strategies for inhibiting mTOR in cancer
Francesca Chiarini, Camilla Evangelisti, James A. McCubrey, et al.
Trends in Pharmacological Sciences (2014) Vol. 36, Iss. 2, pp. 124-135
Closed Access | Times Cited: 252

Metformin as an Anticancer Agent
Aleš Vančura, Pengli Bu, Madhura Bhagwat, et al.
Trends in Pharmacological Sciences (2018) Vol. 39, Iss. 10, pp. 867-878
Open Access | Times Cited: 234

Somatic overgrowth disorders of the PI3K/AKT/mTOR pathway & therapeutic strategies
Kim M. Keppler‐Noreuil, Victoria Parker, Thomas N. Darling, et al.
American Journal of Medical Genetics Part C Seminars in Medical Genetics (2016) Vol. 172, Iss. 4, pp. 402-421
Open Access | Times Cited: 232

Senescence in COPD and Its Comorbidities
Peter J. Barnes
Annual Review of Physiology (2016) Vol. 79, Iss. 1, pp. 517-539
Open Access | Times Cited: 222

Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality
Hua Xu, Melinda C. Aldrich, Qingxia Chen, et al.
Journal of the American Medical Informatics Association (2014) Vol. 22, Iss. 1, pp. 179-191
Open Access | Times Cited: 215

The crucial impact of lysosomes in aging and longevity
Didac Carmona‐Gutiérrez, Adam L. Hughes, Frank Madeo, et al.
Ageing Research Reviews (2016) Vol. 32, pp. 2-12
Open Access | Times Cited: 214

Balancing mTOR Signaling and Autophagy in the Treatment of Parkinson’s Disease
Zhou Zhu, Chuanbin Yang, Ashok Iyaswamy, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 3, pp. 728-728
Open Access | Times Cited: 213

Attention to Background Strain Is Essential for Metabolic Research: C57BL/6 and the International Knockout Mouse Consortium
Danielle Fontaine, Dawn Belt Davis
Diabetes (2015) Vol. 65, Iss. 1, pp. 25-33
Open Access | Times Cited: 208

Taurine deficiency as a driver of aging
Parminder Singh, Kishore Gollapalli, Stefano Mangiola, et al.
Science (2023) Vol. 380, Iss. 6649
Open Access | Times Cited: 208

Sestrins Function as Guanine Nucleotide Dissociation Inhibitors for Rag GTPases to Control mTORC1 Signaling
Min Peng, Na Yin, Ming O. Li
Cell (2014) Vol. 159, Iss. 1, pp. 122-133
Open Access | Times Cited: 206

Rapamycin: An InhibiTOR of Aging Emerges From the Soil of Easter Island
Sebastian I. Arriola Apelo, Dudley W. Lamming
The Journals of Gerontology Series A (2016) Vol. 71, Iss. 7, pp. 841-849
Open Access | Times Cited: 205

The Ras-Erk-ETS-Signaling Pathway Is a Drug Target for Longevity
Cathy Slack, Nazif Alic, A. Reghan Foley, et al.
Cell (2015) Vol. 162, Iss. 1, pp. 72-83
Open Access | Times Cited: 197

Autophagy and aging: Maintaining the proteome through exercise and caloric restriction
Kurt A. Escobar, Nathan Cole, Christine M. Mermier, et al.
Aging Cell (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 194

Anti‐aging pharmacology in cutaneous wound healing: effects of metformin, resveratrol, and rapamycin by local application
Pan Zhao, Bing‐Dong Sui, Nu Liu, et al.
Aging Cell (2017) Vol. 16, Iss. 5, pp. 1083-1093
Open Access | Times Cited: 187

Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
Henry Querfurth, Hankyu Lee
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 183

Lithium Promotes Longevity through GSK3/NRF2-Dependent Hormesis
Jorge Iván Castillo-Quan, Li Li, Kerri J. Kinghorn, et al.
Cell Reports (2016) Vol. 15, Iss. 3, pp. 638-650
Open Access | Times Cited: 178

Therapeutic interventions for aging: the case of cellular senescence
Abel Soto-Gamez, Marco Demaria
Drug Discovery Today (2017) Vol. 22, Iss. 5, pp. 786-795
Open Access | Times Cited: 176

TOR signaling in plants: conservation and innovation
Lin Shi, Yue Wu, Jen Sheen
Development (2018) Vol. 145, Iss. 13
Open Access | Times Cited: 176

Platelet membrane-coated nanoparticle-mediated targeting delivery of Rapamycin blocks atherosclerotic plaque development and stabilizes plaque in apolipoprotein E-deficient (ApoE−/−) mice
Yanan Song, Zheyong Huang, Xin Liu, et al.
Nanomedicine Nanotechnology Biology and Medicine (2018) Vol. 15, Iss. 1, pp. 13-24
Closed Access | Times Cited: 173

Senotherapeutics: emerging strategy for healthy aging and age-related disease
Eok-Cheon Kim, Jae‐Ryong Kim
BMB Reports (2019) Vol. 52, Iss. 1, pp. 47-55
Open Access | Times Cited: 170

A novel rapamycin analog is highly selective for mTORC1 in vivo
Katherine H. Schreiber, Sebastian I. Arriola Apelo, Deyang Yu, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 166

mTOR pathway activation drives lung cell senescence and emphysema
Amal Houssaïni, Marielle Breau, Kanny Kebe, et al.
JCI Insight (2018) Vol. 3, Iss. 3
Open Access | Times Cited: 164

Targeting the biology of aging with mTOR inhibitors
Joan B. Mannick, Dudley W. Lamming
Nature Aging (2023) Vol. 3, Iss. 6, pp. 642-660
Open Access | Times Cited: 163

IgG is an aging factor that drives adipose tissue fibrosis and metabolic decline
Lexiang Yu, Qianfen Wan, Qiongming Liu, et al.
Cell Metabolism (2024) Vol. 36, Iss. 4, pp. 793-807.e5
Closed Access | Times Cited: 30

The role of the immunosuppressive PD-1/PD-L1 checkpoint pathway in the aging process and age-related diseases
Antero Salminen
Journal of Molecular Medicine (2024) Vol. 102, Iss. 6, pp. 733-750
Open Access | Times Cited: 21

Scroll to top